UroGen Pharma (URGN) Net Margin (2017 - 2026)
UroGen Pharma (URGN) reported Net Margin of -19.81% for Q2 2026, up 186.43 percentage points from -206.24% a year earlier and up 26.45 percentage points from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Net Margin (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, UroGen Pharma's Net Margin came in at -51.73%, up 112.71 percentage points year-over-year; for FY2025, it was -139.81%, up 0.54 percentage points from FY2024.
- Net Margin has a five-year change of +949.13 percentage points (FY2020 to FY2025).
- By year, Net Margin came in at -140.35% in FY2024 (-16.74 pp), -123.61% in FY2023 (+46.97 pp), -170.58% in FY2022 (+60.09 pp) and -230.67% in FY2021 (+858.27 pp).
- The Q2 2026 figure ranks as the highest quarterly Net Margin since Q3 2017.
- Year over year, Net Margin has now increased in each of the last three quarters, with an average year-over-year change of +35.40 percentage points over the last eight quarters.
- The high point for year-over-year Net Margin in five years was Q3 2021 (a gain of 566.44 percentage points); the low point was Q2 2025 (a drop of 53.35 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -46.26% (Q1 2026), -69.68% (Q4 2025) and -121.34% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.90 Bn | 1,105.48 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 617.06 Bn | 535.59 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 501.38 Bn | 474.49 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 261.31 Bn | 235.00 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 236.29 Bn | 191.69 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 190.40 Bn | 164.60 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 169.55 Bn | 116.19 Bn | 10.94 Bn | -1.65% |
| 10 | UroGen Pharma | 1.80 Bn | 1.30 Bn | 65.88 Mn | -19.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.81% |
| Mar 31, 2026 | -46.26% |
| Dec 31, 2025 | -69.68% |
| Sep 30, 2025 | -121.34% |
| Jun 30, 2025 | -206.24% |
| Mar 31, 2025 | -216.47% |
| Dec 31, 2024 | -152.71% |
| Sep 30, 2024 | -93.93% |
| Jun 30, 2024 | -152.89% |
| Mar 31, 2024 | -171.91% |
| Dec 31, 2023 | -110.57% |
| Sep 30, 2023 | -104.93% |
| Jun 30, 2023 | -114.18% |
| Mar 31, 2023 | -175.74% |
| Dec 31, 2022 | -159.57% |
| Sep 30, 2022 | -160.47% |
| Jun 30, 2022 | -160.75% |
| Mar 31, 2022 | -209.32% |
| Dec 31, 2021 | -175.91% |
| Sep 30, 2021 | -266.15% |
API Access
UroGen Pharma Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();